These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3324369)

  • 1. Therapy of idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P
    Springer Semin Immunopathol; 1987; 9(4):431-40. PubMed ID: 3324369
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differentiated pathogenetic therapy of glomerulonephritis].
    Belovezhdov N
    Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of membranous nephropathy.
    Ponticelli C; Passerini P
    Nephrol Dial Transplant; 2001; 16 Suppl 5():8-10. PubMed ID: 11509678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C; Zucchelli P; Passerini P; Cesana B
    N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of idiopathic membranous nephropathy].
    Passerini P
    G Ital Nefrol; 2004; 21(6):531-9. PubMed ID: 15593020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis].
    Lagrue G; Bariety J
    Minerva Med; 1970 Jul; 61(55):3054-63. PubMed ID: 5427678
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B
    N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
    Hebert LA; Rovin BH; Agarwal AK; Spetie DN
    Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Grassi C; Limido D; Pasquali S; Passerini P; Volpini T; Locatelli F
    Proc Eur Dial Transplant Assoc; 1983; 19():717-23. PubMed ID: 6348763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current therapeutic possibilities in chronic idiopathic glomerulonephritis].
    Ponticelli C; Fogazzi GB
    Minerva Urol Nefrol; 1985; 37(1):9-12. PubMed ID: 3901338
    [No Abstract]   [Full Text] [Related]  

  • 11. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
    Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pharmacotherapy of chronic glomerulonephritis].
    Ratner MIa; Biriukova LS
    Klin Med (Mosk); 1992 Jan; 70(1):114-9. PubMed ID: 1608196
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of lupus nephritis.
    Pollak VE
    Adv Nephrol Necker Hosp; 1976; 6():137-61. PubMed ID: 828444
    [No Abstract]   [Full Text] [Related]  

  • 14. Membranous nephropathy--still a treatment dilemma.
    Cameron JS
    N Engl J Med; 1992 Aug; 327(9):638-9. PubMed ID: 1640957
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
    Naumovic R; Furuncic D; Jovanovic D; Stosovic M; Basta-Jovanovic G; Lezaic V
    Biomed Pharmacother; 2010 Nov; 64(9):633-8. PubMed ID: 20888177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroids for idiopathic membranous nephritis.
    N Engl J Med; 1977 Jan; 296(1):49-50. PubMed ID: 830273
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Passerini P; Grassi C; Limido D; Pasquali S; Volpini T
    N Engl J Med; 1984 Apr; 310(15):946-50. PubMed ID: 6366560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of efficacy of methylprednisolone, prednisolone and chlorambucil in idiopathic glomerulonephritis.
    Nand N; Das R; Jaswal TS
    J Indian Med Assoc; 1997 Jun; 95(6):163-5, 174. PubMed ID: 9420390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive therapy in primary glomerulonephritis (pros).
    Ponticelli C; Banfi G; Imbasciati E; Tarantino A
    Contrib Nephrol; 1982; (34):33-54. PubMed ID: 6293765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.